Migraine Disorders

23 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Brain Diseases, Nervous System Diseases

Treatments and conditions

Migraine Disorders
Treatment and conditionWhere it standsTrials
Allay Lamp for migraine disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Blood sampling for microRNA testing for migraine disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bocunebart for migraine disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
BR005-036C for migraine disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Elismetrep for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Eptinezumab for migraine disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Erenumab for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)22
Erenumab + calcitonin gene-related peptide for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Erenumab 70 mg + GALCANEZUMAB + ATOGEPANT + EPTINEZUMAB for migraine disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Erenumab matching placebo + ERENUMAB for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Erenumab-Aooe 140 MG/ML [Aimovig] for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Galcanezumab for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Galcanezumab + erenumab + fremanezumab for migraine disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
GALCANEZUMAB + Ubrogepant for migraine disordersPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Green light for migraine disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lidocaine for migraine disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Onabotulinumtoxin-A for migraine disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Placebo + Psilocybin for migraine disordersPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
PRT-064040 nasal spray for migraine disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for migraine disordersPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Transcranial Direct Current Stimulation for migraine disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ubrogepant + ERENUMAB for migraine disordersPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.